Corneal blood staining, a rare but serious complication of cataract surgery, can lead to blurred vision and long-term eye damage. Discover the causes, risk factors, and preventative strategies to protect your sight.
A recent study in Taiwan investigated heavy metal levels in healthy adults, raising important questions about environmental exposure and potential health risks. Learn about the findings, what they mean for you, and how to take proactive steps.
Discover how researchers are leveraging common blood test equipment to identify activated neutrophils, paving the way for quicker diagnosis of bacterial infections and a deeper understanding of immune system activity.
Hepatitis A is usually a mild illness in kids, but sometimes it throws curveballs. Learn about rare complications like brain issues and kidney problems, and how doctors handle these unusual cases.
Stay informed about the latest advancements in prostate cancer management. Explore the role of genetics, improved imaging techniques, and innovative treatments that are reshaping patient care.
This article explores how identifying SCN1A gene mutations can significantly improve the diagnosis of Dravet Syndrome, offering a clearer understanding of the genetic factors involved and paving the way for more effective, targeted treatments.
Discover how to manage rotator cuff tendinopathy with exercises that focus on pain monitoring. This guide synthesizes research to help you find relief and improve function.
Ever wondered why waking up from anesthesia feels different than falling asleep? It's not just about the drugs. This article uncovers a hidden phenomenon called hysteresis, revealing how your brain's unique activity resists the return to consciousness.
Researchers are leveraging 3D bioprinting to construct breast cancer models that mimic the in vivo environment, enhancing the accuracy of drug resistance studies and paving the way for personalized cancer treatments. Learn how this technology is transforming cancer research.
Discover how scientists are unlocking the potential of myeloid immune checkpoints to revolutionize cancer treatment. Learn about the groundbreaking study that combines anti-CD47 antibodies with rituximab, showing promising results in lymphoma patients and introducing a new era of immuno-oncology.
Page 811 of 1036
